Intrexon – A Shameful JPM Healthcare Conference Pump
- Intrexon (XON) licensed a cancer therapy from MD Andersen which cost them $50M in stock. - Intrexon paid an...
(If you're unable to access an article, contact us and we'll email you the full article)
We have an over 90% success rate
3rd Party Verified:
(click on the stock symbols below to see the reports)
Get Our Latest Reports Delivered To Your Inbox (we will not share your email with anyone)